← Back
Data updated: Mar 10, 2026
NIVAGEN PHARMS INC
Oncology
NIVAGEN PHARMS INC is a generic drug manufacturer focused on Oncology. Key products include DECITABINE.
2020
Since
5
Drugs
-
Trials
28
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
TEMOZOLOMIDE 2026-01-22
Labeling
TEMOZOLOMIDE 2026-01-22
Labeling
DECITABINE 2025-12-19
TEMOZOLOMIDE 2025-07-01
Labeling
DECITABINE 2025-07-01
Labeling
DECITABINE 2025-06-20
Labeling
DECITABINE 2025-06-20
Labeling
DECITABINE 2025-06-20
Labeling
ZINC SULFATE 2025-06-10
ZINC SULFATE 2025-05-01
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (0)
Company Info
- First Approval
- 2020-12-07
- Latest
- 2024-07-05
- Applications
- 5